[
  "origin articl variat outcom liver-reduc dietari regimen bariatr surgeri : nation retrospect cohort studi salli abbott , m.res.a , b , * , charlott price , ph.d.c , dimitrio j. pournara , ph.d.d , e , karen coulman , ph.d.d , e , behalf british obes metabol surgeri societi baridiet research group aspecialist weight manag servic , univers hospit coventri warwickshir nh trust , coventri , unit kingdom bresearch centr intellig healthcar , coventri univers , coventri , unit kingdom csigma , coventri univers , frederick lanchest librari , coventri , unit kingdom dpopul health scienc , bristol medic school , univers bristol , bristol , unit kingdom ebristol weight manag bariatr servic , north bristol nh trust , southmead hospit , bristol , unit kingdom receiv 15 april 2022 ; accept 16 octob 2022 abstract background : liver-reduc diet ( lrd ) mandat prior bariatr surgeri , guidelin implementation.object : establish variat effect lrd util clinic practic . set : nationwid , multicent , retrospect cohort studi . method : total 1699 adult patient across 14 bariatr center unit kingdom includ . multilevel logist regress model develop examin factor predict of5 % weight loss . result : center ( n 59 ) prescrib 800- 1000-kcal diet , durat formu- lation diet variabl . overal , 30.6 % ( n 5510 ) patient achiev 5 % weight loss lrd . adjust preoper weight , women reduc odd ( odd ratio [ ] , .65 ; 95 % con\ufb01denc interv [ ci ] , .48\u2013.88 ; p5.005 ) , increas age ( , 1.01 ; 95 % ci , 1.00\u20131.02 ; p5.043 ) type 2 diabet ( , 1.49 ; 95 % ci , 1.16\u20131.92 ; p5.002 ) increas odd 5 % weight loss . normal consist food lrd ( , .64 ; 95 % ci , .42\u2013.98 ; p5.041 ) energi prescript .1200 kcals\/d ( , .33 ; 95 % ci , .13\u2013.83 ; p5.019 ) reduc odd , lrd durat 3 week ( , 2.28 ; 95 % ci , 1.02\u20135.09 ; p5.044 ) greater increas odd 5 % weight loss.conclus : wide variat lrd deliv clinic practic , highlight need evidence-bas consensu . \ufb01nding suggest optim lrd bariatr surgeri contain 800 1200 kcals\/d durat 3 4 week . research requir determineth optim formul lrd whether women may requir lower-energi lrd men . ( surg obe relat di 2022 ; -:1\u20137 . ) \/c2112022 american societi metabol bariatr surgeri . publish elsevi inc. right reserv . open access articl thecc licens ( http : \/\/creativecommons.org\/licenses\/by\/4.0\/ ) . keyword : liver-reduc diet ; low-energi diet ; low\u2013energi diet ; bariatr surgeri ; nutrit ; preoper optim * correspond : salli abbott , m.res. , research centr intellig healthcar , richard crossman build , coventri cv1 5fb , unit kingdom.e-mail address : sally.abbott @ coventry.ac.uk ( s. abbott ) . http : \/\/doi.org\/10.1016\/j.soard.2022.10.027 1550-7289\/ \/c2112022 american societi metabol bariatr surgeri . publish elsevi inc. right reserv . open access articl cc licens ( http : \/\/creativecommons.org\/licenses\/by\/4.0\/ ) . surgeri obes relat diseas - ( 2022 ) 1\u20137obes character excess adipos tissu , result nonalcohol fatti liver diseas ( nafld ) dueto exagger synthesi deposit triglyceridesin hepatocyt [ 1 ] . bodi mass index ( bmi ) signi\ufb01c posit correl liver steatosi [ 2 ] compar normal bmi ; obes increas risk developingnafld 3.5-fold [ 3 ] . preval nafld among patient undergo bariatr surgeri report high 81 % 90 % [ 4,5 ] . nafld present oper challeng laparo- scopic bariatr surgeri , liver retract necessitatedto gain access stomach , therefor bariatr centersaround world mandat short-term preoper liver-reduc diet ( lrd ) . lrd facilit deplet glycogen lipid store liver , result reduct liver volum improv liver \ufb02exibl [ 6 ] . lrd also result rapid weight loss reduc viscer adipos [ 7 ] , enabl improv access stomach . lrd affect patientoutcom varieti mechan , includingreduct surgeon \u2019 perceiv complex proced-ur [ 8 ] , improv whole-bodi insulin sensit [ 9 ] , possibl reduct risk postop complic [ 10 ] . lrd support guidelin periop care bariatr surgeri enhanc recoveri aftersurgeri ( era ) societi recommend [ 11 ] , signi\ufb01c posit correl total weightloss hepat volum reduct lrd prior bar-iatr surgeri [ 8 ] therefor weight loss pragmat marker liver volum reduct . common practic patient undergo bariatr surgeri support toward 5 % weight loss im- mediat period surgeri , reduc hepat volum [ 12 ] . european societi clinic nutrit meta- bolism guidelin clinic nutrit liver diseas [ 13 ] recommend low-energi diet effect interven- tion achiev weight loss least 5 % signi\ufb01cantimprov liver steatosi nafld . among patientsundergo bariatr surgeri , 5 % weight loss pre- oper dietari regimen result hepat volum reduc- tion 15.6 % [ 8 ] 23.0 % [ 14 ] . systemat review [ 12 ] synthes \ufb01nding 8 random control trial ( rct ) examin effec-t lrd achiev 5 % weight loss . lrd of700 1050 kcals\/d minimum durat 3 weekssupport attain 5 % weight loss . howev , de\ufb01nit evidence-bas conclus unabl drawn studi , due limit number trial heterogen natur lrd intervent . high variabl lrd deliv within multipl countri across world [ 15\u201318 ] . re\ufb02ect lack conclus evid optim type , content , durat lrd [ 19 ] , result european [ 20 ] us [ 21 ] clinic practiceguidelin unabl make evidence-bas recommen- dation deliveri lrd . henc , aim thisstudi establish variat , weight loss out-com , lrd current use clinic practic acrossmultipl bariatr center unit kingdom ( uk ) . method studi popul conduct uk multicent retrospect cohort studi examin weight loss outcom lrd beforebariatr surgeri . open invit sent dietitian , invit nomin bariatr center contributedata studi . invit sent member aclos onlin discuss forum ( googl group ) regis-t dietitian work bariatr servic uk . particip studi , center requir access patient record detail prescrib lrd andweight lrd individu patient level . adult patient ( \/c2118 year age ) underw primari bariatr procedur fund nation healthservic ( nh ) januari 1 decemb 31,2019 , elig inclus . adult eligiblefor nh fund bariatr surgeri uk , supervis weight manag program must undertaken 6 12 month support specialist multidis-ciplinari team ( mdt ) start bmi \/c2140 kg\/m 2or 35 40 kg\/m2with obesity-rel co-morbid [ 22 ] . patient exclud lrd interven- tion weight outcom data miss patientrecord . data collect data collect site level exist patient record includ patient demograph ( sex , age , ethnic ) , type 2 diabet ( t2d ) statu , lrd intervent ( prescrib energi intak [ kcal ] ) , formul , durat , whether patient could choos diet fol-low ) , anthropometr ( weight , bmi ) startingth lrd day surgeri , lrd ended.in uk clinic practic , patient undergo bariatr sur-geri may experi short-notic surgeri cancel , lead prolong lrd . therefor , exten- sion durat lrd also record , includ reason . data anonym particip sitesbefor transfer data lead research foranalysi . weight loss use pragmat surrog marker liver size reduct . \/c215 % weight loss achiev via nutrit intervent result clinic improvementsin hepat steatosi [ 13 ] , henc , primari outcom attain 5 % weight loss day surgeri . ethic approv grant coventri univers ethic committe , coventri , uk ( p130160 ) .salli abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 2data analysi analys undertaken use spss version 26. descript statist use explor individu patientcharacterist intervent factor associ withachiev 5 % weight loss . c 2test use explor asso- ciation differ element dietari interven- tion achiev 5 % weight loss . sinc data werecollect across sever differ bariatr center , multilevellogist regress model develop investig fac-tor predict 5 % weight loss , adjust cluster , sinc patient cluster ( i.e. , group ) within center . \ufb01rst step , null model \ufb01tted data . bariatr center includ model random effect sinc likelihood ratio test statist signi\ufb01c 5 % level . indic differ bariatr center ac-count variabl attain 5 % weightloss surgeri . individu level characterist thenad \ufb01xed effect model remov one-by-oneus manual backward elimin approach didnot achiev statist signi\ufb01c base cut-point ofp5.05 . includ age ( yr ) , sex ( male\/femal ) , t2d sta- tu baselin ( yes\/no ) , weight baselin ( kg ) , ethnic whether diet extend ( yes\/no ) . final , element ofth lrd ad model remov one timeaccord strategi . includ daili energyprescript ( kcal ) , recommend diet durat ( wk ) , dietformul , whether patient given choic ofdiet ( yes\/no ) . choic diet effect bariatriccenter-level variabl ( level 2 ) sinc bariatr center studi either gave patient choic . lrd element almost level-2 variabl , littlewithin-cent variabl . result fourteen 55 nh fund bariatr center uk particip studi . total 1817 patientswer elig 1669 includ analysis:8.1 % ( n 5148 ) exclud due miss data ( diet record n 56 , baselin weight record n 56 , sur- geri weight record n 5136 ) . baselin characterist mean patient age 46.8 year ( standard deviat , 11.1 ) . cohort predominantli femal ( 79.4 % , n51325 ) white ( 81.9 % , n 51367 ) . total 462 pa- tient ( 27.7 % ) t2d median bmi baselin 45.6 kg\/m 2 ( interquartil rang [ iqr ] , 41.3\u201351.1 ) ( tabl 1 ) . dietari intervent variat prescrib lrd particip bariatr center ( supplement 1 ) . particip center ( n 59 ) prescrib 800- to1000-kcal diet . choic diet offer patient half center ( n 57 ) , , center , main prescrib dietari formul milk diet ( n52 ) , milk yogurt diet ( n 53 ) , normal consis- tenci food diet ( n 52 ) . remain center ( n 57 ) gave patient autonomi choos lrd formula-t , could also includ meal replac formula-t . durat lrd standard patient 7 center , regardless patient \u2019 bmi , 6 center prescrib 2-week durat 1 center prescrib- 3-week durat . across bariatr center ( n57 ) , durat lrd depend upon bmi , wherebi patient higher bmi \/c2150 or\/c2160 kg\/m 2were prescrib longer durat lrd , rang 3 12 week . patient undertook lrd prescrib dura- tion , small number patient underw prolong lrd ( n 5129 , 7.7 % ) median durat 14.5 day ( iqr , 7\u201328 day ) . reason prolong durat oflrd mainli due reschedul surgeri datesdu bed capac surgeon avail ( n 5106 ) . weight loss outcom mean weight loss baselin surgeri 5.30 kg ( 95 % con\ufb01denc interv [ ci ] , 5.06\u20135.54 ) 510patient ( 30.6 % ) achiev 5 % weight loss ( tabl 2 ) . result multilevel logist regress model investig 5 % weight loss shown tabl 3 . null model show signi\ufb01c random effect bariatr center ( p5.039 ) , effect disappear af- ter account characterist patient thelrd . adjust weight surgeri , patient fac-tor improv odd 5 % weight loss includedincreas age , male sex , t2d . particular , odd achiev 5 % weight loss women werearound .6 time odd men account thetabl 1 baselin characterist particip ( n 51669 ) characterist valu age ( yr ) , mean ( sd ) 46.8 ( 11.1 ) male , n ( % ) 344 ( 20.6 % ) ethnic , n ( % ) white 1367 ( 81.9 % ) black 60 ( 3.6 % ) south asian 50 ( 3.0 % ) 62 ( 3.7 % ) unknown 130 ( 7.8 % ) diabet , n ( % ) diabet 1207 ( 72.3 % ) type 2 diabet 447 ( 26.8 % ) type 1 diabet 15 ( .9 % ) weight ( kg ) , mean ( sd ) 130.6 ( 25.6 ) bmi ( kg\/m 2 ) , mean ( sd ) 46.8 ( 7.8 ) sd5standard deviat ; bmi 5bodi mass index.s abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 3other factor model ( adjust odd ratio [ ] , .648 ; 95 % ci , .479\u2013.875 ; p5.005 ) . element lrd impact- ing 5 % weight loss includ diet formul , prescrib energi intak , diet durat . normal con-sist food diet less like achiev 5 % weight losscompar liquid consist diet ( adjust , .643 ; 95 % ci , .421\u2013.982 ; p5.041 ) , odd achiev 5 % weight loss increas week diet , 3 week show signi\ufb01c bene\ufb01t just1 week.tabl 2 5 % weight loss dietari intervent ( n 51669 ) dietari intervent total achiev 5 % weight loss , n ( % ) pvalu * 1669 510 ( 30.6 % ) - choic diet , .001 ye 682 280 ( 41.1 % ) 987 230 ( 23.3 % ) kcal , .001 ,800 65 20 ( 30.8 % ) 800\u20131000 985 381 ( 38.7 % ) 1000\u20131200 512 93 ( 18.2 % ) .1200 107 16 ( 15.0 % ) formul , .001 nonsolid food 1136 290 ( 25.5 % ) food 227 68 ( 30.0 % ) meal replac 73 37 ( 50.7 % ) meal replac 1food 233 115 ( 49.4 % ) durat , .001 1 wk 88 12 ( 13.6 % ) 2 wk 1160 302 ( 26.0 % ) 3 wk 194 76 ( 39.2 % ) 4 wk 170 87 ( 51.2 % ) \/c215 wk 57 33 ( 57.9 % ) * c 2test independ . tabl 3 result random effect logist regress model ( n 51669 ) fix effect coef\ufb01cient adjust odd ratio ( 95 % ci ) pvalu intercept \u20132.571 .076 ( .019 , .305 ) , .001 age .011 1.011 ( 1.000 , 1.022 ) .043sex : femal \u2013.434 .648 ( .479 , .875 ) .005diabet : ye .401 1.493 ( 1.159 , 1.924 ) .002 baselin weight ( kg ) .007 1.007 ( 1.002 , 1.013 ) .011 diet extend : ye .569 1.766 ( 1.139 , 2.739 ) .011kcal ,800 - - - - 800\u20131000 .144 1.155 ( .578 , 2.305 ) .683 1000\u20131200 \u2013.627 .534 ( .257 , 1.113 ) .094.1200 \u20131.099 .333 ( .133 , .832 ) .019 diet formul nonsolid food - - - - food \u2013.441 .643 ( .421 , .982 ) .041meal replac .220 1.246 ( .693 , 2.240 ) .461 meal replac 1food .283 1.327 ( .856 , 2.057 ) .206 durat 1w k - - - -2 wk .478 1.613 ( .794 , 3.277 ) .186 3 wk .825 2.282 ( 1.023 , 5.086 ) .044 4 wk 1.091 2.977 ( 1.283 , 6.905 ) .011.5 wk 1.254 3.504 ( 1.331 , 9.222 ) .011 random effect varianc ( 95 % ci ) .036 ( .003 , .411 ) .415 ci5con\ufb01d interval.s abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 4discuss \ufb01rst multicent studi nation scale examin outcom rang lrd util clin-ic practic bariatr surgeri . previou researchha shown \/c215 % weight loss bariatr surgeri shown reduc liver volum 23.0 % [ 8,14 ] . \ufb01nding suggest less third ( 30.6 % ) patient un-dertak lrd bariatr surgeri \/c215 % weight loss . also found greater varia-t formul energi prescript lrd uti-l uk clinic practic , compar 2012 [ 18 ] . variat lrd intervent durat lrd util today \u2019 clinic practic akin 2012 practic [ 18 ] , wherebi three quarter patient ( 76.7 % ) studi prescrib shorter dura-t diet ( \/c202 week ) , compar 75 % bariatr cen- ter 2012. howev , report prescribedenergi formul lrd becom variabl today \u2019 practic . 2012 , center provid data prescrib low-energi diet ( led ) 800 1000 kcals\/d common formul lrd normalconsist food ( 59 % ) . studi , commonformul lrd liquid consist food ( 68.1 % ) , variat energi prescription.th heterogen natur lrd intervent within ourstudi surpris , given intern clinic guidelin [ 20,21 ] specifi recommend lrd deliv practic . patient characterist men characterist higher bodi mass ( kg ) greater fat free mass ( % ) women [ 23,24 ] , therefor men higher rest energi expenditur ( ree ) [ 25 ] . 16 % greater weight loss report among men compar women follow \ufb01xed led of810 kcal 8 week [ 23 ] . none bariatr center includ studi prescrib lower-energi lrd forwomen compar men , may explain \ufb01nd-ing women reduc odd attain 5 % weight loss , suggest women prescrib alower-energi prescript compar men . patient t2d greater odd achiev 5 % weight loss lrd compar withoutdiabet . larg retrospect cohort studi usand canada [ 26 ] , patient achiev .5 % .10 % weight loss also like t2d ( p\/c20.001 ) . acknowledg collect data t2d med-ic glycem control studi , thereforefurth research requir examin \ufb01nding , particular whether diabet pharmacotherapi , glp-1 receptor agonist , may explain greater weight lossamong patient t2d lrd period.lrd energi prescript \ufb01nding support use energi restrict ,1200 kcals\/d , either form led ( 800\u20131200 kcals\/d ) low\u2013energi diet ( vled ) ( ,800 kcals\/d ) . howev , would argu clinic practic , led en- ergi prescript may prefer recommend patient . parallel random trial 3-weekvl versu led bariatr surgeri [ 8 ] , inter- vention signi\ufb01cantli decreas hepat volum ( \u201315.6 % , p5.045 ; \u201312.3 % , p5.045 , respect ) , moreov , differ reduct hepat volumebetween group ( p5.409 ) . addit , signi\ufb01cantli higher proport particip vled group re- port advers event dizzi physic weak ( p\/c20.05 ) . ketonuria measur also indic 26 % patient compliant vledbefor bariatr surgeri , suggest dif\ufb01culti adher- level energi restrict [ 27 ] . led may favor minim transient in- creas liver enzym report duringlrd prior bariatr surgeri . random control trial 3-week vled ( 800 kcals\/day ) versu led ( 1200 kcals\/day ) lrd , adjust , signi\ufb01c in-creas alt vled group 12.3 u\/l ( p5.001 ) , led group ( p5.108 ) . although enzym elev transient shown normal aperiod weight stabil [ 28 ] , less restrict led may favor vled , minim exacerb ofliv injuri preparatori period surgeri . lrd formul patient follow normal consist food lrd reduc odd attain 5 % weight loss , comparedwith liquid consist food diet . propos liquidconsist food formul lrd restrict conveni prepar convent food . inde , rct liquid versu normal consist foodlrd [ 27 ] , viscer fat signi\ufb01cantli lower 2 week liquid ( \u201320.6 % ) compar normal consistencyfood ( \u2013.28 % ) lrd ( p5.041 ) . howev , liquid lrd formul self-report hunger signi\ufb01cantli higher among liquid versusnorm consist food-bas diet group 1 week ( p5.004 ) 2 week ( p\/c20.0001 ) [ 27 ] . inhibitori control impair adult obes [ 29 ] henc solid viscou formul meal replac , com-bin meal replac 1food formul , may prefer- abl manag hunger level increas complianc . lrd durat compar 1-week lrd , lrd \/c213 week in- creas odd attain 5 % weight loss . previousresearch examin chang liver volum asal abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 56-week vled bariatr surgeri , measur obtain 2 , 4 , 6 week [ 30 ] . conclud 4-week durat ideal period lrd , sinc livervolum reach maximum reduct 4 week , suggest- decreas complianc lrd 4 6week . howev , measur taken the3-week timepoint distinguish 3 4 week oflrd optim durat . lrd \/c215 week durat may unnecessari could neg impact patient complianc [ 31 ] , negat potenti bene\ufb01t extend durat lrd . strength limit main strength studi larg sampl size across multipl center generaliz \ufb01ndingsto intern clinic practic , popul wasre\ufb02ect intern demograph characteristicsof patient undergo bariatr surgeri [ 32 ] . limit studi includ retrospect approach datacollect , meant small proport elig popul ( 8.1 % ) exclud analysi due miss data ; feasibl obtain measurementsof chang liver volum obtain data macronu-tri composit lrd util . focu studi preoper period , henc examin whether weight loss lrdsin\ufb02uenc postop outcom . although individualstudi examin lrd postop complic show con\ufb02ict \ufb01nding , era societi recommend [ 11 ] conclud avail literatur moder level evid lrd reduc postopera-t complic . howev , owe mortal event ratesb low follow bariatr surgeri dif\ufb01cult ascer-tain whether preoper weight loss lrd associ- mortal risk [ 33 ] . 5 % weight loss recommend reduc liver steato- si nafld [ 13 ] , howev limit studi within bariatr surgeri popul [ 8,14 ] examin whether optim weight loss signi\ufb01cantli reduc livervolum lrd whether inde associatedwith reduct postop complic . henc , measur chang liver volum postoperativedata larg sampl patient requir con\ufb01rm thata 5 % weight loss appropri recommend within popul group . conclus wide variat way lrd deliv clinic practic , suggest consensu lrd deliv clinic practic need . \ufb01nding support liquid consist food , mealreplac combin meal replac 1normal consist food formul , contain 800 1200kcals\/d , durat 3 4 week effectivelrd 5 % weight loss bariatr surgeri . womenmay requir lower-energi lrd men , shouldb examin research . final , given widevari lrd deliv , need forfurth prospect , high-qual research con\ufb01rm \ufb01nding determin precis formul lrd effect evidence-basedconsensu lrd clinic practic reach tostandard patient care . acknowledg work support british dietet associ- ation obes specialist group ( research , audit , eval- uation grant , 2020 ) . author give special thank member british obes metabol surgerysocieti baridiet research group ( kate colban , sarahmatthia , lisa cant , michel soobayah , maisi rowley , luci rout , guy holt , kate waller , charlott birkett , mela-ni langley , tom chapman , kate rust , abi johnson , pris-cila gonsalez , vanessa osborn , emili cooper , emmalittl , helen kingett , ami kirk , nausheen hamid , dervla kavanagh , georgia windrass , emma white , madelein william , lauren bateman , natali conway , aimeenewton ) , made studi possibl carri outdata collect within respect bariatr unit . disclosur s. abbott receiv speaker honoraria johnson & johnson educ event . d.j . pournara fund royal colleg surgeon england . re- ceiv consult fee johnson & johnson paymentsfor lectur , present , educ event john-son & johnson , medtron , novo nordisk . k. coulman , clinic lectur ( ica-cl-2018-04-st2-008 ) , fund byhealth educ england\/n institut healthresearch ( nihr ) , bristol centr surgic research , nihr bristol weston biomed research centr ( variou grant ) univers hospit bristol weston nh foundat trust univers bris-tol . view express public theauthor necessarili nihr , nh , theuk depart health social care , royal collegeof surgeon england , medic research council . supplementari materi supplementari materi associ articl found , onlin version , http : \/\/doi.org\/10.1016\/ j.soard.2022.10.027 .salli abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 6refer [ 1 ] parker r. role adipos tissu fatti liver diseas . liver re 2018 ; 2 ( 1 ) :35\u201342 . [ 2 ] fan r , wang j , du j. associ bodi mass index fatti liver risk : dose-respons analysi . sci rep 2018 ; 8 ( 1 ) :115273 . [ 3 ] li l , liu dw , yan hy , wang zy , zhao sh , wang b. obes in- depend risk factor non-alcohol fatti liver diseas : evid meta-analysi 21 cohort studi . obe rev 2016 ; 17 ( 6 ) :510\u20139 . [ 4 ] soresi , cabibi , giglio r , et al . preval nafld \ufb01brosi bariatr surgeri patient reliabl noninvas diagnost method . biom re int 2020 ; 2020:5023157 . [ 5 ] losekann , weston ac , de carli la , espindola mb , pioner sr , coral gp . nonalcohol fatti liver diseas sever obes patient , subject baria tric surgeri . arq gastroenterol 2013 ; 50 ( 4 ) :285\u20139 . [ 6 ] edholm , kullberg j , haenni , et al . preoper 4-week low- calori diet reduc liver volum intrahepat fat , facilit laparoscop gastric bypass morbidli obes . obe surg 2011 ; 21 ( 3 ) :345\u201350 . [ 7 ] collin j , mccloskey c , titchner r , goodpast b , hoffman , hauser , et al . preoper weight loss high-risk superobes bar- iatric patient : comput tomography-bas analysi . surg obe relat di 2011 ; 7 ( 4 ) :480\u20135 . [ 8 ] gil contrera , bonada sanjaum , montero jaim , et al . ef- fect two preoperatori weight loss diet hepat volum , meta- bolic paramet , surgic complic morbid obesebariatr surgeri candid : random clinic trial . obe surg2018 ; 28 ( 12 ) :3756\u201368 . [ 9 ] pournara dj , nygren j , hagstr \u20acom-toft e , arner p , le roux cw , thorel a. improv glucos metabol gastric bypass : evolu-t paradigm . surg obe relat di 2016 ; 12 ( 8 ) :1457\u201365 . [ 10 ] van nieuwenhov , dambrauska z , campillo-soto , et al . preop- er low-calori diet oper outcom laparoscop gastric bypass : random multicent studi . arch surg2011 ; 146 ( 11 ) :1300\u20135 . [ 11 ] stenberg e , do rei falc ~ao lf , \u2019 kane , et al . guidelin peri- oper care bariatr surgeri : enhanc recoveri surgeri ( era ) societi recommend : 2021 updat . world j surg2022 ; 46 ( 4 ) :729\u201351 . [ 12 ] naseer f , shabbir , livingston b , price r , syn nl , flanneri o. ef\ufb01caci energy-restrict diet achiev preoper weightloss bariatr patient : systemat review . obe surg2018 ; 28 ( 11 ) :3678\u201390 . [ 13 ] plauth , bernal w , dasarathi , et al . espen guidelin clinic nutrit liver diseas . clin nutr 2019 ; 38 ( 2 ) :485\u2013521 . [ 14 ] chakravartti , vivian g , mullholland n , et al . preoper liver shrink diet bariatr surgeri may impact wound heal : ran- domiz control trial . surg obe relat di 2019 ; 15 ( 1 ) :117\u201325 . [ 15 ] kolen , romeijn mm , holthuijsen ddb , janssen l , greve jwm , leclercq wkg , et al . current preoper strategi appli dutch bariatr center : nation survey . clin obe 2021 ; 11 ( 4 ) : e12461 . [ 16 ] bourn r , tweedi j , pelli f. preoper nutrit manag bariatr patient australia : current practic dietitian . nutr diet 2018 ; 75 ( 3 ) :316\u201323 . [ 17 ] holderbaum ms , buss c. dietari manag immedi pre- oper period bariatr surgeri : nation overview : bariatricpreop diet . obe surg 2018 ; 28 ( 6 ) :1688\u201396 . [ 18 ] baldri el , leeder pc , idri ir . pre-op dietari restrict patient undergo bariatr surgeri uk : observ studyof current practic dietari effect . obe surg 2014 ; 24 ( 3 ) :416\u201321 . [ 19 ] kim jj , roger , ballem n , schirmer b. asmb updat posit statement insur mandat preoper weight loss require- ment . surg obe relat di 2016 ; 12 ( 5 ) :955\u20139 . [ 20 ] di lorenzo n , antoni sa , batterham rl , et al . clinic practic guidelin european associ endoscop surgeri ( eae ) bariatr surgeri : updat 2020 endors ifso-ec , easo espcop . surg endosc 2020 ; 34 ( 6 ) :2332\u201358 . [ 21 ] mechanick ji , apovian c , brethauer , et al . clinic practic guide- line periop nutrit , metabol , nonsurg sup- port patient undergo bariatr procedur \u2013 2019 updat : cosponsor american associ clinic endocrinologists\/american colleg endocrinolog , obes societi , american societi metabol & bariatr surgeri , obes medicin associ- ation , american societi anesthesiologist \u2013 execut sum-mari . endoc pract 2019 ; 25 ( 12 ) :1346\u201359 . [ 22 ] nation institut care health excel ( nice ) [ internet ] . london : institut ; publish 27 nov 2014 [ updat 2022 sep 8 ; cite 2022 septemb 11 ] . obes : identi\ufb01c , assess andmanag clinic guidelin [ cg189 ] ; [ 56 screen ] . avail : http : \/\/www.nice.org.uk\/guidance\/cg189\/resources\/obesity- identi\ufb01cation-assessment-and-management-pdf-35109821097925 . [ 23 ] christensen p , meinert larsen , et al . men women respond differ- entli rapid weight loss : metabol outcom multi-centr inter- vention studi low-energi diet 2500 overweight , individu pre-diabet ( preview ) . diabet obe metab 2018 ; 20 ( 12 ) :2840\u201351 . [ 24 ] bredella . sex differ bodi composit . adv exp med biol 2017 ; 1043:9\u201327 . [ 25 ] nocito , ballard , shaw j. human energi requir : report joint fao\/ who\/unu expert consult . food nutr bull 2005 ; 26 ( 1 ) :166 . [ 26 ] sun , liu b , smith jk , et al . associ preoper bodi weight weight loss risk death bariatr surgeri . jama netwopen 2020 ; 3 ( 5 ) : e204803 . [ 27 ] faria sl , faria op , cardeal mda , ito mk . effect low cal- ori diet preoper stage bariatr surgeri : random trial . surg obe relat di 2015 ; 11 ( 1 ) :230\u20137 . [ 28 ] gasteyg c , larsen tm , vercruyss f , astrup a. effect dietary- induc weight loss liver enzym obes subject . j clin nutr 2008 ; 87 ( 5 ) :1141\u20137 . [ 29 ] lavagnino l , arnon , cao b , soar jc , selvaraj s. inhibitori control obes bing eat disord : systemat review meta-analysi neurocognit neuroimag studi . neurosci biobehav rev 2016 ; 68:714\u201326 . [ 30 ] gonz \/c19alez-p \/c19erez j , \/c19anchez-leenh , delgado ar , et al . clinic impact 6-week preoper low calor ie diet bodi weight liver size morbidli obes patient . obe surg 2013 ; 23 ( 10 ) :1624\u201331 . [ 31 ] coll sl , dixon jb , mark p , strauss bj , \u2019 brien pe . preoper weight loss very-low-energi diet : quantit chang inliv abdomin fat serial imag . j clin nutr 2006 ; 84 ( 2 ) :304\u201311 . [ 32 ] ramo , kow l , brown w , et al . 5th ifso global registri report [ monograph internet ] . read , u.k. : dendrit clinic sys- tem ltd ; 2019 [ cite 2022 mar 30 ] . avail : http : \/\/www . ifso.com\/pdf\/5th-ifso-global-registry-report-september-2019.pdf . [ 33 ] roman , monaghan , serraino gf , et al . meta-analysi in\ufb02u- enc lifestyl chang preoper weight loss surgic out- come . br j surg 2019 ; 106 ( 3 ) :181\u20139 .salli abbott et al . \/ surgeri obes relat diseas - ( 2022 ) 1\u20137 7"
]